On February 3, 2022 Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, reported that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present in a fireside chat format at the virtual 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 12:00 pm ET (Press release, Aligos Therapeutics, FEB 3, 2022, View Source/news-releases/news-release-details/aligos-therapeutics-present-11th-annual-svb-leerink-global" target="_blank" title="View Source/news-releases/news-release-details/aligos-therapeutics-present-11th-annual-svb-leerink-global" rel="nofollow">View Source [SID1234607730]). Both the presentation and the Q&A session will be held virtually.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An audio webcast of the presentation will be available using the webcast registration link or through the Aligos investor section of the website. View Source

The Aligos management team will also participate in investor 1×1 meetings during the conference. Please contact your SVB Leerink representative to schedule virtual one-on-one meetings with Aligos during the conference. For more information about the 11th Annual SVB Leerink Global Healthcare Conference, please refer to the Events Website.